BAP1 has a high somatic mutation rate in uveal melanoma and mesothelioma but very few mutations in lung cancer, suggesting that another regulation pathway may be involved in the dysregulation of BAP1 in lung cancer [27-31]. Here, BAP1 is linked to mesothelioma.